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ABSTRACT
The neurofibromatosis Type 1 (NF1) gene functions as a tu-
mor suppressor gene. One known function of neurofibromin,
the NF1 protein product, is to accelerate the slow intrinsic
GTPase activity of Ras to increase the production of inac-
tive rasGDP, with wide-ranging effects on p21ras pathways.
Loss of neurofibromin in the autosomal dominant disorder
NF1 is associated with tumors of the peripheral nervous
system, particularly neurofibromas, benign lesions in which
the major affected cell type is the Schwann cell (SC). NF1
is the most common cancer predisposition syndrome affect-
ing the nervous system. We have developed an in vitro sys-
tem for differentiating mouse embryonic stem cells (mESC)
that are NF1 wild type (1/1), heterozygous (1/2), or null
(2/2) into SC-like cells to study the role of NF1 in SC de-
velopment and tumor formation. These mES-generated SC-
like cells, regardless of their NF1 status, express SC
markers correlated with their stage of maturation, includ-
ing myelin proteins. They also support and preferentially
direct neurite outgrowth from primary neurons. NF1 null
and heterozygous SC-like cells proliferate at an acceler-
ated rate compared to NF1 wild type; this growth advant-
age can be reverted to wild type levels using an inhibitor
of MAP kinase kinase (Mek). The mESC of all NF1 types
can also be differentiated into neuron-like cells. This novel
model system provides an ideal paradigm for studies of
the role of NF1 in cell growth and differentiation of the
different cell types affected by NF1 in cells with differing
levels of neurofibromin that are neither transformed nor
malignant. VC 2007 Wiley-Liss, Inc.
INTRODUCTION
NF1 is the most common human cancer predisposition
syndrome affecting the nervous system (Gutmann et al.,
2001). Hallmarks of NF1 include a range of symptoms
from cafe au lait spots of the skin to tumors of the pe-
ripheral nervous system. Schwann cells (SC) have been
found to be the originating cell type in most of the
benign tumors (Harrisingh and Lloyd, 2004; Zhu et al.,
2002) and can also contribute to malignant peripheral
nerve sheath tumors (Lee et al., 2004; Miller et al.,
2006). Loss of heterozygosity (LOH) is frequently seen in
NF1 tumors, particularly in the SC population (Zhu et
al., 2002), although not all SCs in the tumors analyzed
showed LOH (Rutkowski et al., 2000; Sawada et al.,
1996; Serra et al., 2000).
The functions of neurofibromin, the protein product of
the neurofibromatosis Type 1 (NF1) gene, are largely
unknown, although investigators have speculated that
other activities will be found in addition to its known
function of accelerating the hydrolyzation of active
rasGTP to inactive rasGDP (Friedman et al., 1999).
When NF1 is mutated, Ras is constitutively active, ena-
bling affected cells to proliferate extensively. This prolif-
eration can result in tumor formation, particularly in
neural crest-derived cells in the peripheral nervous sys-
tem, which have the highest neurofibromin expression
(Cichowski and Jacks, 2001; Daston et al., 1992; Fried-
man et al., 1999). A good deal of interest has recently
been focused on neural crest-derived SC stem cells and
very early stage precursors of SC, which are hypothe-
sized to be the neurofibroma-originating cells in NF1
(Parada et al., 2005; Zhu et al., 2005). It would be very
helpful to devise a model system in which differentiation
of SC with different levels of neurofibromin could be fol-
lowed from the ‘‘stem cell’’ to the fully differentiated SC
under a variety of environmental conditions, particu-
larly if the cells were as close to ‘‘normal’’ as possible—
that is, neither transformed nor malignant. We have
now devised such a model system, using mouse embry-
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onic stem cells engineered to express variable levels of
neurofibromin (Jacks et al., 1994). These mouse embry-
onic stem (mES) cells can be differentiated into most of
the cell types affected in NF1.
Previous studies by Sieber-Blum and colleagues dem-
onstrated that neuregulin-1 (Nrg-1) promotes the differ-
entiation of neural crest (NC) stem cells into SCs
(Sieber-Blum et al., 2004). Neural crest cells are embry-
onic transitory migratory cells that differentiate into
many cell types (Dorsky et al., 2000; Kalcheim and Bur-
styn-Cohen, 2005; Le Douarin et al., 2004; Lobsiger
et al., 2002), including those of the peripheral nervous
system affected in NF1, including SCs and neurons
(Cichowski and Jacks, 2001; Daston and Ratner, 1992;
Vogel et al., 1995). Before becoming mature SC, which
can be either myelinating or nonmyelinating, NC cells
pass through SC precursor and immature SC stages.
Myelination by SC requires the presence of large diameter
neurites (Bunge et al., 1980, 1982; Ratner et al., 1986).
We have used media containing neuregulin to produce
a SC differentiation model using mouse ES (mES) cells
that have one (NF11/2), both (NF11/1), or neither
(NF12/2) functional allele. All three cell types have the
potential to differentiate into many different kinds of
cells, including neuron-like cells (Fig. 1A) and Schwann-
like cells (Fig. 1B). They provide an ideal system to
study the effects of the environment on the gene expres-
sion cascades involved in the differentiation of cell types
that make variable levels of neurofibromin and that are
implicated in the progression of neurofibromatosis 1.
MATERIALS AND METHODS
Cell Types
The cell lines used for these studies include the follow-
ing: the D3 (NF11/1) mES cell line (Doetschmann,
1985), the SKO (NF11/2) mES cell line (Jacks et al.,
1994), and a DKO (NF12/2) mES cell line with the NF1
gene disrupted by insertion of a neo cassette replacing
exon 31 (Jacks et al., 1994). Control cell lines included
the SW10 (NF11/1) mouse SC line, which carries a
temperature sensitive SV40 large T antigen and which
is grown at 37C (the nonpermissive temperature for
transgene expression) for differentiation studies (ATCC,
Manassas, VA), as well as primary rat SC, grown as pre-
viously described (Lisak and Bealmear, 1991).
Media
Proliferating (ES): 81% DMEM without phenol red,
1% L-Glut, 1% Pen/Strep, 1% nonessential amino acids
(Gibco, Carlsbad, CA), 15% FBS (Atlanta Biological, Nor-
Fig. 1. Undifferentiated mES cells that express various levels of
neurofibromin grow in mounds but can be differentiated into neuron-
like cells and SC-like cells. NF1 expression is upregulated following SC
differentiation. Cell types are listed in the leftmost box of each row. A:
Self-renewing mES cells express Oct4 (blue). NF1 expression (green) is
strong in D3 (NF11/1) cells, weakly expressed in SKO (NF11/2) cells,
and not expressed in DKO (NF12/2) cells. Tuj1 (red), a neuronal
marker, was weakly expressed around the edges of colonies, showing
some differentiation in cells on the periphery (left). After 5 days growth
in neuronal differentiation media, Tuj1 expression was strongly
observed in the neurites of neuron-like cells; Oct4 expression decreased
and was only seen in some clumps of cells in large colonies (center and
right). B: Left column illustrates SC-like morphology of mES cells, sim-
ilar to the morphology of the SW10 SC line and primary rat SC. (332
mag. with phase 1 filter). Middle column shows expression of S100 and
right column shows GFAP expression (340 mag). C: RTqPCR shows
NF1 expression in SKO cells is 55% of the level in D3 cells; expression
in DKO cells is undetectable. After SC differentiation, NF1 expression
increased 150% in both D3SC cells and SKOSC cells, but is undetect-
able in DKOSC cells.
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cross, GA), 1% sodium pyruvate (2% stock), 7 lL/L b mer-
captoethanol (Sigma, St. Louis, MO), 1,000 U/mL ESGRO
(Chemicon, Temecula, CA). Neuronal differentiation: 95%F-
12, 1% Pen/Strep, 1% N2, 2% B27 (Gibco), 2% sodium pyru-
vate (2% stock), 0.5 lg/L bFGF, 1 lg/L IL-7, 5 lg/L IGF-1
(Sigma), either 1 lg/L CNTF (R1 D) or 1 lg/L NGF (Chem-
icon). SC differentiation: 84% a-modified MEMwithout phe-
nol red, 1% Pen/Strep (Gibco), 10% FBS (Atlanta Biological),
5% 11-day chick embryo extract, 10 ng/mL NRG-1 (R&D
systems, Minneapolis, MN). SW10 media: 88% DMEM
without phenol red, 1% l-glutamine, 1% Pen/Strep, 10%
FBS (Atlanta Biological). Primary rat SC media: 90%
DMEM (Gibco), 10% FBS (Atlanta Biological). Minimal
media: 87% DMEMwithout phenol red, 1% Pen/Strep, 1% l-
glutamine (Gibco), 10% FBS (Atlanta Biological), 1% sodium
pyruvate (Gibco).
Antibodies
We used antibodies to: NF1 (rabbit polyclonal 1:50),
Oct4 (goat polyclonal 1:50) (Santa Cruz, CA), Tuj1 (mouse
monoclonal 1:500) (Covance, Berkeley, CA), Neurofila-
ment (rabbit polyclonal 1:400) (Chemicon, Temecula, CA),
S100 (rabbit polyclonal 1:200) (Novocastra, Newcastle
Upon Tyne, UK) or mouse monoclonal (1:50) (Abcam,
Cambridge, MA), GFAP (mouse monoclonal 1:400) (Chem-
icon), peripheral myelin basic protein (mouse monoclonal
1:10), Ki67 (rabbit polyclonal 1:100) (Abcam), a-tubulin
(mouse monoclonal 1:200), AlexaFluor 350, 488, 594,
DAPI (Molecular Probes, Eugene, OR), goat a rabbit-
HRP (1:500) (Zymed, San Francisco, CA).
Reagents
Reagents included: Histomouse kit (Zymed), Prolong
Gold anti-fade (Molecular Probes), Porcine gel (Sigma),
CellTiter96 cell proliferation assay (Promega). All anti-
bodies were diluted in 10% donkey serum (Chemicon) in
0.1% Tween20/phosphate buffered saline (PBS) (Sigma).
Differentiation of mES Cells into
Neuron-Like Cells
mES cells in ES medium were plated onto Primaria
(Falcon) plates and allowed to attach overnight. After 24 h,
cells were washed 13 with PBS (GIBCO formulation) and
the medium was changed to neuronal differentiation me-
dium containing either 1 lg/L CNTF or 1 lg/L NGF. Undif-
ferentiated mES cells were fed daily, while cells in neuronal
differentiation media were fed every other day. After 5 days’
growth, cells were labeled for expression of NF1, Oct4 (self-
renewing mES cells), and Tuj1 (neuronal differentiation).
Differentiation of mES Cells into SC-Like Cells
mES cells in ES medium were plated onto Primaria
(Falcon) plates and allowed to attach overnight. After
24 h, cells were washed 13 with PBS and the medium
was changed to SC medium. Cells were fed every other
day and passed when confluent (every 5–6 days). After
1 week, cells had the appearance of SC-like cells (flat
and spindly), and proliferation rate was assessed and
found to have decreased. After 2 weeks in SC-differen-
tiation medium cells were examined by RTqPCR for
changes in NF1 gene and protein expression and immu-
noassayed for S100 and GFAP expression. After 1
month, cells were assayed for the ability to initiate and
direct neurite outgrowth and to produce myelin. Cells
have been frozen and thawed and remain proliferative
and SC marker-expressing over at least 20 passages.
Immunocytochemistry
About 40,000 cells were plated onto 0.1% porcine gel-
coated (Sigma) coverslips (Corning, Corning, NY) and
grown overnight. Cells were then fixed in 4% parafor-
maldehyde (Sigma), permeabilized in 0.2% TritonX-100
(Sigma), stained, and mounted onto Superfrost plus
slides (Fisher, Pittsburgh, PA). The Zymed Histomouse
kit was used according to the manufacturer’s instruc-
tions for nonfluorescent ICC using mouse monoclonal
antibodies. Fluorescence micrographs were taken with
an Olympus BX-51 microscope, and nonfluorescent
micrographs with Nikon ACT-1 software on a Leitz Dia-
vert inverted microscope.
RTqPCR
RTqPCR was performed using primer pairs designed
using the Beacon designer program (BioRad, Hercules,
CA), with target Ta at 55C, length 18–22 bp, and
amplicon size 100–200. SW10 gene expression was nor-
malized to GAPDH. A comparison of gene expression in
SC-like mES cells with undifferentiated mES cells was
done by dividing the expression in SC differentiated
cells by the expression in proliferative undifferentiated
mES cells. Quantification of SC marker expression was
assayed at the time points listed in supplemental Table 1.
To assay SC-like cells’ myelin gene upregulation in the
presence of neurons, day E5 chick statoacoustic ganglia
(SAGs) were excised and added at time points listed and
grown an additional 7 days before RTqPCR analysis.
Total RNA from the samples was extracted using Qiagen
mRNA Kit 74106 (Qiagen, Valencia, CA).
RT-PCR was performed as follows: cDNA was synthe-
sized from 2 lg total RNA by reverse transcription using
Super Script III transcriptase (Invitrogen, Carlsbad, CA)
and oligo dT primer. The PCR conditions included an
initial denaturation at 94C for 1 min, 94C for 1 min,
55C for 30 s and 74C for 30 s and 34 cycles and final
extension at 72C for 5 min and 4C holding tempera-
ture. The PCR products were separated on 2.0% agarose
gels and visualized using ethidium bromide (staining)
under UV light.
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PCR Primers
NF1: forward: AGTTTCTCTCCTCGCTGGTCTTC; reverse:
CGTTTCCTGCCACCCGTTTG; Oct4: forward: CCAACGA
GAAGAGTATGAGG; reverse: CTGAGTAGAGTGTGGTGA
AG. a4integrin: forward: GAATCTCCTCCACCTACTCAC
AG; reverse: CCAACGGCTACATCAACATATCC; Cad19: for-
ward: GGAGGAGACAGACAAGATG; reverse: TGAAGGA
GTGATGGTAGATG; PMP22: forward: GCTCTGTTCCTG
TTCTTC TG; reverse: TGCCTCACTGTGTAGATGG; MBP:
forward: AGACCCTCACAGCGATCCAAG; reverse: AGTC
AAGGATGCCCGTGTCTC; a1b1integrin: forward: CAGTG
AATGGCAACAATGAAG; reverse: ATCAGCAGCAAGGC
AAGG.
Measurement of Proliferation rates of mES cells during
SC-like differentiation: 30,000 cells per well were counted
and plated onto Primaria (Falcon) 24-well plates. Prolifer-
ation was assayed at specific time points using immuno-
cytochemistry with the Ki67 antibody, which recognizes
cells in active cell cycle. If indicated, E5 chick statoacous-
tic ganglia (SAGs), which are destined to innervate the
inner ear, were excised and added to the plate and grown
for an additional 3 days before the assay was performed.
The percentage of Ki67-positive cells compared to total
cell number was used to determine the proliferation rate.
Microsoft Excel was used to graph and analyze the data,
which are expressed as mean 6 SD.
Proliferation Rates of mES Cells After
Addition of U0126 Mek Inhibitor
To determine whether the Ras pathway might be
implicated in overproliferation of NF11/2 and NF12/2
SC-like cells compared to wild type cells, 10,000 cells
per well were plated onto 96-well Primaria plates. After
1 h, either 4 lM U0126 (Mek inhibitor) or ethanol (vehi-
cle control) was added to wells and cells were allowed to
grow for 3 days. Proliferating cells were identified using
the CellTiter96 (Promega) proliferation assay and ab-
sorbance was measured at 492 nm by a microplate
reader (Fisher). Absorbance is directly proportional to
the number of actively cycling cells.
Statoacoustic Ganglion Neurite Outgrowth
and Directional Outgrowth in the
Presence of SC-Like Cells
To test for SC-supported neurite outgrowth and
directed neurite outgrowth, statoacoustic ganglia (SAGs)
from E5 chick embryos (Bianchi et al., 2005) were
excised and plated onto undifferentiated mES cells (D3,
SKO, or DKO), SC-differentiated mES cells (D3SC,
SKOSC, DKOSC), or SW10SC cells. After 5 days, cul-
tures were assayed for the presence or absence of neu-
rite outgrowth (neurofilament positive neurites) as well
as the percentage of the area occupied by SAG-neurite
positive cells and processes. The total area of SAG neu-
rite positive cells and process outgrowth was quantified
using Metamorph software (Universal Images Corp)
threshold image analysis by determining the percent of
Neurofilament-stained cell/neurite area compared to the
total area.
To determine whether SAG neurite outgrowth was
preferentially directed towards SC-differentiated cells,
we excised and plated SAGs on culture dishes to which
undifferentiated mES cells and SC-like cells were subse-
quently added on coverslips in two different quadrants
of the plate separated by 180 but equidistant from the
SAG at the center. We first allowed the SAGs to attach
overnight and then added the two coverslips; one con-
taining undifferentiated mES cells and the other cover-
slip containing SC-like cells. These cultures were grown
for 5 days and assessed for (a) preferential direction of
neurite outgrowth, (b) any contact between the mES
cells (SC-differentiated or undifferentiated) and the neu-
rites. Neurites in each half of the plate were assessed
for extension toward each cell type (undifferentiated vs.
SC-differentiated).
RESULTS
SC-Like Morphology in Neuregulin-Containing
SC Medium
SC lineage markers characteristic of maturation are
sequentially expressed and NF1 expression increases in
cultures of mES-derived SC-like cells.
We exposed the (D3 NF11/1, SKO NF11/2, and
DKO NF12/2) mES cells to SC differentiation medium.
After growing for 1 week in SC media, fed every second
day, all cell types (D3 NF11/1, SKO NF11/2, and DKO
NF12/2) flattened out and took on the spindly appear-
ance characteristic of SC. All these cells also expressed
two different SC proteins, S100 and GFAP, as did the
SW10 mouse SC line and the primary rat SC (Fig. 1B,
compare with mouse SC line SW10 and primary rat SC
in bottom rows). Hereafter, SC-like differentiated mES
cells will be referred to as D3SC, SKOSC, and DKOSC,
for D3 (WT-NF11/1), SKO (single knock out-that is
missing one NF1 allele; NF11/2), or DKO (double knock
out; NF12/2) respectively.
Because exon 31 had been replaced by a neo cassette
in these mutant NF1 cells (Jacks et al., 1994), we were
able to target this area to design primers to quantify
NF1 expression. RTqPCR confirmed NF1 expression in
undifferentiated D3 and SKO cells. NF1 was not
expressed in DKO cells (Fig. 1C). The NF1 expression
levels in D3 cells were set at 100%. This level was used
to determine NF1 expression levels of SKO (55%) and
DKO (0%) cells, and all SC-differentiated cells. NF1
expression was upregulated 150% after 2 weeks in
SC-differentiation media in D3SC (from 100 to 152%)
and SKOSC (from 55 to 85%) cells, while remaining
at undetectable levels in DKOSC (Fig. 1C). NF1 was
also expressed in SW10 SC and primary rat SC (not
shown).
To determine whether all three differentiating mES
cell types followed all the characteristic stages of differ-
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entiation into mature SC, we also examined gene
expression at various stages of differentiation from un-
differentiated ES cells to mature SC, using as markers
genes characteristic for these stages (Jessen and Mirsky,
1991; Lobsiger et al., 2002). These included the following
stages/markers: Undifferentiated ES (Oct4), neural crest
stem cell (a4integrin), SC progenitor (Cad19), immature
SC (PMP22), to mature myelinating SC (myelin basic
protein-MBP) or nonmyelinating SC (a1b1integrin). We
found that Oct4 (Fig. 2A) was most highly expressed on
day 0 in culture, becoming undetectable in all cell types
with continued culture in SC-differentiation media.
Both DKO and SKO cells expressed lower levels of Oct4
on day 0 than D3 cells. By contrast, markers of SC-dif-
ferentiation, such as a4integrin (Fig. 2B) and Cad19
(Fig. 2C), were more gradually upregulated, while genes
characteristic of more mature SCs, including PMP22
(Fig. 2D) the expression of which persists through myeli-
nation, MBP (Fig. 2E), and a1b1integrin (Fig. 2F), gen-
erally needed the presence of SAG neurites to stimulate
their highest expression levels (Fig. 2 and supplemen-
tary Table 1). An exception to this was seen in DKOSC
(NF12/2) cells, in which MBP was downregulated in
the presence of SAG neurites.
Effect of The Overproliferation of NF1-Deficient
or Null SC-Like Cells Can Be Reduced by
Exposure to a Mek Inhibitor, U0126,
on Proliferation Rates
NF11/1 mES cells had higher proliferation rates
than NF1 deficient mES cells (Fig. 3A, day 0), but after
Fig. 2. Expression of SC lineage markers is upregulated with time. A:
Oct4, expressed in undifferentiated ES cells, is highly expressed on day 0
in all cell types, especially D3 (NF11/1) but is not detectable after SC-dif-
ferentiation. B: a4integrin, expressed in neural crest and SC precursors,
C: Cad19, expressed in SC precursors, and D: PMP22, expressed in imma-
ture SC, as well as myelinating and nonmyelinating SC, are either unde-
tectable or expressed at very low levels in undifferentiated ES cells but
are all detectable following culture in SC differentiation medium. E and
F: Two markers of mature SC are upregulated in the presence of SAG
neurites. MBP, expressed in myelinating SC, is more highly upregulated
in D3SC (NF11/1) cells; a1b1integrin, expressed in nonmyelinating SC,
is most highly expressed in DKOSC (NF12/2) cells.
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day 9 in SC-differentiating conditions NF1 deficient cells
had higher proliferation rates than NF11/1 cells
(D3SC) (Fig. 3A, days 18 and 28), which could be due to
constitutively active Ras. D3SC cells’ proliferation rate
was comparable to that of SW10 SC (47%). As quies-
cence is expected for SC in the presence of neurites, fol-
lowing chick statoacoustic ganglion (SAG) addition to
the culture, NF11/1 cells (D3SC, SW10) became less
proliferative, with 34 and 29% actively cycling cells,
respectively (Fig. 3A, rightmost set). By contrast, most
SKOSC (70–60%) and DKOSC (77–66%) cells remained
in active cell cycle (Fig. 3A). Ki67 expression was seen
in nonaxonal-associated clumps of proliferative SKOSC
(NF11/2) and DKOSC (NF12/2) cells among the SAG
neurites (Fig. 3B).
The overproliferation seen in SKOSC and DKOSC
cells could be reverted to WT levels by the addition of
4 lM U0126, a Mek inhibitor (Favata et al., 1998),
implicating the Ras pathway in this overproliferation,
since this pathway is constitutively active following the
loss of NF1 function (Fig. 3C).
Effect of SC-like Differentiation of mES Cells
on Myelin Basic Protein Expression and Neurite
Outgrown from Statoacoustic Ganglia
We found that neurite outgrowth and complexity of
neurite formation and branching in chick statoacoustic
ganglia (SAG) was increased in the presence of mES
cells that had become SC-like (Fig. 4). Excised SAGs
from E5 chick embryos plated onto undifferentiated
mES (D3, SKO or DKO) cells, SC-differentiated (D3SC,
SKOSC, or DKOSC) mES cells or SW10 SC cells had
markedly different neurite outgrowth patterns. We
found that undifferentiated mES cells, regardless of
their NF1 genotype and NF1 expression level, did not
support either neurite outgrowth or myelin production,
while SAGs grown on any of the SC-differentiated cells
(Fig. 4A) supported extensive neurite outgrowth over 5
days, with branching processes that were never seen in
cultures of SAGs alone (Fig. 5B), or on defined sub-
strates such as poly-L-lysine, even in neurite outgrowth
promoting medium (Bianchi et al., 2005). Sometimes
Fig. 3. Proliferation rates differ among cell types based on NF1 geno-
type. A: NF11/1 mES cells have higher proliferation rates, determined
by percentage of cells in active cell cycle (Ki671) than NF1 deficient mES
cells (day 0). SC-like differentiated NF1 deficient cells had higher prolifer-
ation rates than NF11/1 cells. By 28 days in SC-differentiation media,
D3SC cells had the same percentage (47%) of cells in cell cycle as SW10
SC, while SKOSC and DKOSC cells were hyperproliferative (70 and 77%,
respectively). Following addition of SAG cells to the culture, NF11/1 cells
(D3SC, SW10) showed reduced proliferation, with only about 30% of cells
in cell cycle, while NF11/2 (SKOSC) and NF12/2 (DKOSC) still had
over 60% of cells in cell cycle. B: Staining for Ki67-positive cells: prolifera-
tive clumps of nonaxon associated SKOSC and DKOSC cells are seen
(green) (3100 mag.). C: Overproliferation of NF11/2 and NF12/2 SC-dif-
ferentiated cells may be dependent on Ras signaling. SKOSC (NF11/2)
and DKOSC (NF12/2) cells proliferate at a significantly increased rate
over that of D3SC (NF11/1) cells. This overproliferation can be decreased
to wild type levels through application of 4 lM U0126, an inhibitor of the
Mek component of the Ras pathway.
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outgrowth was so extensive, especially on NF1 deficient
and NF1 null cells, that it obscured our ability to dis-
cern the shape of the original SAG (especially see
SKOSC Fig. 4A, middle row to the right).
We next determined whether the SAGs needed physi-
cal cell–cell contact with the SC-like cells or if the cells
could affect the directionality of neurite outgrowth with-
out direct contact. Excised SAGs were plated on culture
dishes on which undifferentiated mES cells (Fig. 4C, on
the left) and SC-like cells (Fig. 4C, on the right) were
subsequently added equidistant from the SAG center on
coverslips in two different quadrants of the plate 180
apart. After 5 days growth, in every case the SAGs pref-
erentially extended neurites toward/over the SC-like
mES cells, and almost invariably veered around undif-
ferentiated ES colonies without making contact (Fig.
4C). Although undifferentiated ES cells did not seem to
inhibit the initiation of neurite outgrowth, neurites that
had begun to grow out from the side of the explant
nearer the undifferentiated ES cells turned and
extended towards the differentiated SC-like mES cells
(n 5 4 for each cell type). Over the 5-day observation
period, the cells of both types continued to proliferate
(ES cells at a faster rate than the SC-like cells) (Fig.
4C), with cells migrating off the coverslip, so that the
undifferentiated cells sometimes grew very near to the
SAGs, causing the neurites to veer around these colonies
(purplish mounds) of undifferentiated mES cells (Fig. 4).
When neurite outgrowth in the half of the plate that
contained SC-differentiated mES cells was compared to
that in the other half of the plate, occupied by undiffer-
entiated mES cells, the direction of neurite outgrowth
was always found to be towards the SC-like cells; neu-
rites that began by traveling toward the undifferenti-
ated cells changed course and veered towards the SC-
like cells in every case (n 5 5). Even though the cells
were grown without LIF (ES) or Nrg-1 (SC) supplements
to the medium, they kept their respective morphological
appearance over the 5 days of the assay.
Expression of Myelin Basic Protein, SAG
Neurite Extension and Branching
To assay whether the SC-like cells were recapitulating
the maturation patterns of rodent primary SC that are
normally seen in vitro as well as in vivo studies (Bunge
et al., 1980), we determined whether the SC-like mES
cells expressed myelin proteins and became associated
with neurites in the presence of primary SAG neurons.
We plated and cultured the SAGs and either SC-like
cells or SW10 SC for 5 days, after which the cells were
labeled for either PNS myelin protein expression using a
mouse monoclonal antibody to peripheral myelin and
the Histomouse kit (Fig. 5A, left column), or analyzed
for a combination of Tuj1 (for neurites) and DAPI (nu-
clear stain) for visualizing SCs’ association with neurites
(Fig. 5A, right column). With the Histomouse kit, we
were able to demonstrate that the SC-like cells as well
as SW10 SC that did express myelin clustered around
Fig. 4. mES cells which had been dif-
ferentiated into SC-like cells, but not un-
differentiated mES cells, directionally
stimulated neurite outgrowth from chick
SAGs. Cell types are listed in each box.
A: E5 chick SAGs were labeled with anti-
bodies to Tuj1 (red). Little or no neurite
outgrowth was directed toward undiffer-
entiated mES cells, but extensive out-
growth was seen toward SC-like cells
(Undifferentiated photographs 320 and
SC-like cells 310 mag.). B: SAGs plated
on the TC substrate equidistant between
coverslips of undifferentiated mES cells
(left side) and SC-like differentiated
mES cells (right side): Neurite outgrowth
was preferentially directed towards the
SC-like cells. Undifferentiated mES cells
are seen as purple mounds (34 mag.).
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what appear to be axons that were expressing neuronal
markers (Fig. 5A, left column). In the two NF11/1 cell
lines (D3 and SW10), myelin positive cells were associ-
ated with the axons of the SAG and there was very little
SC growth anywhere on the rest of the plate. In SKOSC
and DKOSC cultures, however, cells farther away from
the neurites did not express myelin and became very
confluent. Many clusters of SKOSC and DKOSC were
seen not to be associated with neurites (Fig. 5A, left and
right column).
To be sure that cells that may have been excised with
the SAG were not those producing the observed myelin
expression, we also grew SAGs on plates without any
additional cells in the same medium used to culture SC
or SW10 cells. SAGs or associated cells did not express
myelin under any of these conditions (Fig. 5B top two
Fig. 5. SC-like cells stimulate SAG neurite outgrowth, express mye-
lin protein, and associate with neurites. A: E5 chick SAGs plated onto
SC-like mES cells or SW10 SC after 5 days: SC-like cells cluster around
neurites and express myelin protein (deep purple; left column). D3SC
and SW10 cells (both NF11/1) associated only with the neurites;
SKOSC (NF11/2) and DKOSC (NF12/2) cells grew to confluency over
the entire plate (left column, 310 magnification). In A, right column,
DAPI stained nuclei of the SC-like cells are seen associated with red
Tuj1-stained neurites of the SAG (3100 magnification). B: Excised SAGs
grown in media alone without an underlying cell layer did not extend
neurites or express myelin (340 magnification). C: SAG neurite out-
growth is dependent on NF1 status of underlying cells. Greater migra-
tion and neurite outgrowth and branching of the SAG neurites is seen in
the presence of SKOSC (NF11/2) (lower panel in B) and DKOSC
(NF12/2) cells. C: Neurite extensions and neuronal cell somata (Tuj1
stained regions) were measured using Metamorph threshold image anal-
ysis software. Although total neuron/neurite area was greatest in cul-
tures of D3SC, neurite area was greatest in DKOSC cultures.
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boxes). Most SAGs did not extend any neurites at all
under these conditions (Fig. 5B, top right); occasionally,
neurite extension was initiated, but these neuritic pro-
cesses were confined to areas around the SAG, without
extending onto the plate (Fig. 5B, top left).
Next, we wanted to determine whether there were dif-
ferences in the area of the plate occupied by neurons or
neurites that varied with the levels of NF1 expression in
the co-cultured SC. To quantify the amount of neurite
outgrowth, we used the Metamorph software program to
measure the percentage of the area covered by neurite
outgrowth, as represented by Tuj1 or neurofilament
antibody staining, compared to the total area. We found
that D3SC cells stimulated SAGs and their associated
neurites to cover significantly more area than SKOSC
cells or DKOSC cells (Fig. 5C). Although the D3SC cells
stimulated more total neuron/neurite-positive area,
much of this area was seen to be in clumps of the SAG
cell bodies themselves rather than in neurite extensions
over the SC lawns. SAGs grown in the presence of
SKOSC and DKOSC cells appeared to have more neu-
rite branching over the areas of the plate with underly-
ing SC-like cells (Fig. 5B, bottom). We next subtracted
the Tuj1- or neurofilament-positive clumps of SAG
somata from the total area and measured only the
extent of neurite outgrowth and branching seen with
the Metamorph program. DKOSC and SKOSC cultures
had higher percentages of neurite positive areas com-
pared to the total area than D3SC (Fig. 5C). However,
SKOSC and DKOSC also had more SC-like mES prolif-
erating cells that were not associated with SAG neurites
(Fig. 5A) than were found in co-cultures with D3SC.
DISCUSSION
We have devised a model system to study the role of
NF1 in SC development and tumorigenesis in which the
levels of neurofibromin are known prior to differentia-
tion and the developmental stage/status in their progres-
sion along the SC maturation pathway is also known.
More importantly, they are neither transformed nor ma-
lignant, as are most of the human or rodent cell lines
used in studies of NF1, especially those used in tumor
progression studies. Comparisons of the role of NF1 in
the stem cells’ differentiation into neurons, SC, and
other cell types affected in the disorder should allow us
to identify key steps in the differentiation processes that
may be susceptible to malignant transformation. In this
study, mES cells were differentiated into SC-like cells in
order to more closely approximate the originating cell
type in both neurofibromas and more advanced tumors
(Zhu et al., 2002), which is now believed to be a stem
cell or early SC progenitors rather than the mature dif-
ferentiated SC.
Neuregulin-1 (Nrg-1) had been found to differentiate
neural crest stem cells into SCs (Sieber-Blum et al.,
2004). We used a modified version of this Nrg-1-contain-
ing medium to direct the differentiation of wild type
(D3) mES cells into SC-like cells, which in their mor-
phology, reduction of proliferation rates and sequential
acquisition of SC markers as they matured in culture,
closely resembled the normal SC developmental progres-
sion. On the basis of the information from their condi-
tional mouse models, Zhu et al. (2005) and Parada et al.
(2005) hypothesize that inactivation of NF1 in SC pre-
cursors or in neural crest stem cells, but not in differen-
tiated SCs, is required for neurofibroma formation. Our
model system will allow us to test this hypothesis fur-
ther in future experiments by implanting SC-like cells
derived from mES cells along mouse nerve roots in both
NF1 compromised mice and in their unaffected litter-
mates to determine tumor status and tumor progression.
In vivo, there is a close relationship between neurons
and SCs (Bunge et al., 1980; Lobsiger et al., 2002; Wood,
1976). Myelinating SC wrap around one or more individ-
ual large-diameter axons; nonmyelinating SCs insulate
small-diameter neuron bundles that are imbedded in the
cytoplasm and surrounded by plasma membrane (Lob-
siger et al., 2002). SCs are unlikely to express myelin
unless they are in the presence of neurons (Coman
et al., 2005; Lobsiger et al., 2002). Genes that are upre-
gulated later in SC development (PMP22) as well as
mature SC genes expressed in myelinating (MBP) and
nonmyelinating (a1b1integrin) SC were expressed at
their highest levels in the cultures in our study only fol-
lowing exposure to SAG neurites, with the exception of
DKOSC cells’ MBP expression, which was decreased in
the presence of SAGs. This could be due to overprolifera-
tion, aberrant SC/neurite interactions, or because the
SAGs showed greater branching of neurites when grown
in co-culture with DKOSC cells, which may result in the
production of smaller diameter axons that are not my-
elinated. Two characteristics of neurofibromas include
hypercellularity of SC and disengagement of SC from
axons (Ling et al., 2005). In our study, although there
was a consistent and close association between the
D3SC and primary neurites of the SAG, and in some
cases, SKOSC and DKOSC were also found associated
with neurites, there were also large numbers of these
neurofibromin compromised SC that remained unassoci-
ated with neurites and which grew in large clumps.
Consistent with NF1’s function as an inactivator of
the Ras pathway (Friedman et al., 1999; Kogut et al.,
2007; Mattingly et al., 2006), DKOSC (NF12/2) and
SKOSC (NF11/2) cells showed significantly increased
cell proliferation rates when compared to D3SC cells,
and aberrant proliferative cells unassociated with SAG
neurites in co-culture. When we inhibited this pathway
using U0126, a Mek inhibitor (Favata et al., 1998; Kogut
et al., 2007; Mattingly et al., 2006), we were able to
return proliferation rates to WT levels. This indirectly
indicates that the inability of neurofibromin-deficient
cells to hydrolyze Ras effectively resulted in overprolifer-
ation. D3SC (NF11/1) cells, which are able to hydrolyze
and inactivate Ras, were unaffected by U0126 addition.
However, more direct tests of Ras pathway involvement
are needed, including direct measurements of ERK1/2
phosphorylation (Adler et al., 2005), before we can do
more than suggest a Ras involvement in these processes.
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To stimulate myelin expression and to determine axo-
nal association, we examined the ability of the mES-
derived SC-like cells to interact with neurites of primary
chick statoacoustic ganglia (SAG). The SAG innervates
the inner ear and individual neurites are myelinated
(Bianchi et al., 2005; Whitlon et al., 2006). It has been
suggested that direct interaction with SC serves as a
substrate for neuron attachment and growth, such as
with SAGs (Whitlon et al., 2006). We found that neurite
outgrowth from SAGs was increased in the presence of
mES cells that had become SC-like, when compared to
undifferentiated mES cells, mouse embryonic fibroblasts
(not shown) or in media alone without an underlying
cell layer. This was the case regardless of their NF1 ge-
notype and NF1 expression level, although NF1 deficient
cells exhibited more elaborate branching and smaller di-
ameter neurites. The SAGs grown on SC-like cells sup-
ported extensive directional neurite outgrowth over the
5-day culture period. SAG neurites that had begun to
grow out from the side of the explant nearer the undif-
ferentiated ES cells turned and extended towards the
differentiated SC-like mES cells, suggesting either a
chemoattractant or growth-promoting signal from the
SC-like cells or a repulsive signal from the undifferenti-
ated mES cells. We have recently found that these SC-
like cells make and upregulate two neurite outgrowth
promoting cytokines, macrophage migratory inhibitory
factor (MIF), and monocyte chemoattractant protein 1
(MCP1) (data not shown), which we have demonstrated
is a powerful neurotrophic cytokine for SAG neurons
(Bianchi et al., 2005). Ratner’s group (Ling et al., 2005)
also reported MCP1 to be upregulated in SC during tu-
mor progression. SC-like mES cells express myelin pro-
tein and associate with axons in the presence of SAG
neurites. SC and SC-like cells that expressed myelin
clustered around the neurite processes. In the two
NF11/1 cell lines (D3 and SW10), myelin-positive cells
clustered around the axons, but there was very little cell
growth on the rest of the plate, again suggesting a possi-
ble chemoattractant component produced by the SC-like
cells that could be MCP1 or MIF. We could not, however,
document any evidence of SC-like cells wrapping around
neurites in these cultures, as did others with primary
SC and neurons in culture (Ratner et al., 1986). SC that
wrap around neurons greater than 1 lM diameter have
been shown to myelinate, while SC associated with
axons smaller than 1 lM diameter are nonmyelinating.
This could explain why MBP (myelinating SC) expres-
sion was higher in D3SC/SAG co-cultures and
a1b1integrin (associated with nonmyelinating SC)
expression was higher in SKOSC/SAG and DKOSC/SAG
co-cultures.
From these experiments we conclude that NF1 (1/1,
1/2, or 2/2) mESC can differentiate in vitro into SC-
like cells that express appropriate SC genes in the
expected order of expression for SC maturation. They
support, and preferentially direct primary ganglion neu-
rite outgrowth, and express myelin in cells near neu-
rites. In vitro, NF11/1 SC-like cells (D3SC) are more
likely to express myelinating SC genes, and become qui-
escent in the presence of SAG neurites at a rate similar
to SW10 mouse SC. NF11/2 (SKOSC) and NF12/2 SC-
like cells (DKOSC) are more likely to stimulate greater
neurite outgrowth and branching, express nonmyelinat-
ing genes, and slightly reduce proliferation in the pres-
ence of SAG neurites. Overproliferation of NF1 deficient
(SKOSC) and null (DKOSC) SC-like cells can be reduced
to NF1/1 (D3SC) levels by the addition of a Mek inhibi-
tor, indirectly indicating Ras pathway involvement. This
paper is the first of which we are aware that shows that
mES cells can be preferentially directed down the SC
pathway. Since all three mES cell lines, regardless of
their NF1 status, can respond by differentiating into
SC-like cells, these cells can be used in further studies
of the function of SC with varying levels of neurofibro-
min in tumor formation and growth.
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